Xiao-Dong Zhu
4PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 06, 2025
Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysis.Hui-Chuan Sun, Xiao-Dong Zhu, Zi-Yi Wang
|Mar 04, 2025
Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon's Perspective.Xiao-Dong Zhu, Lei Zhao, Binkui Li
|Nov 04, 2024
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis.Peiyi Xie, Lei Guo, Qiang Yu
|May 09, 2020
NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.Kang-Shuai Li, Xiao-Dong Zhu, Hong-Da Liu
Pageof 1
